Drugs / Pregabalin
Pregabalin
also known as
Lyrica · PGB · CI-1008 · YHD1119 · PGL · GLA5PR GLARS-NF1 · S+ 3-isobutyl GABA · averopreg · +22 more
Regulatory milestones approvals, filings & regulatory actions · 8 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (6) | US (FDA) | LYRICA | — | 2007-06-21 – 2019-05-23 | fda.gov ↗ |
| Approved | US (FDA) | LYRICA | — | 2004-12-30 | fda.gov ↗ |
| Approved | EU (EMA) | Lyrica | — | 2004-07-05 | europa.eu ↗ |
Trials 312 · started per year
today
EU approved 2004
US approved 2004
1
2
2
4
4
6
17
18
22
18
19
20
22
14
10
14
11
10
8
8
8
11
12
10
7
14
7
12
19971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 07 trials | ||||||
| Phase 0 | NCT06600607 | Oct 2024 | — | Latigo Biotherapeutics | Completed | No outcome recorded |
| Phase 0 | NCT05292066 | Oct → Dec 2022 | neuropathy, painful | Aga Khan University | Unknown | No outcome recorded |
| Phase 0 | NCT04648540 | Dec 2020 → Aug 2022 | — | Cairo University | Completed | No outcome recorded |
| Phase 0 | NCT01511640 | Feb 2017 → Mar 2020 | substance-related disorder | University of Kentucky | Completed | No outcome recorded |
| Phase 0 | NCT00470093 | Oct 2007 → Jan 2010 | plasma cell myeloma | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Terminated | No outcome recorded |
| Phase 0 | NCT00644137 | Aug 2007 → Feb 2010 | nicotine dependence | Yale University | Completed | No outcome recorded |
| Phase 0 | NCT00583869 | May 2007 → Aug 2009 | — | University of Alabama at Birmingham | Completed | No outcome recorded |
| Phase 135 trials | ||||||
| Phase 1 | NCT07618715 | Jun → Aug 2026 overdue | — | Neurodawn Pharmaceutical Co., Ltd. | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT07013773 | May → Jul 2025 overdue | — | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| Phase 1 | NCT06935721 | Mar → May 2025 overdue | — | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| Phase 1 | NCT06935682 | Jan → May 2025 overdue | — | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| Phase 1 | NCT06512155 | Jul → Nov 2024 | sleep disorder | Mengchang Yang | Completed | No outcome recorded |
| Phase 1 | NCT06077786 | Oct 2023 → May 2024 | — | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase 1 | NCT05012436 | Jul 2021 → May 2022 | impaired renal function disease | Yuhan Corporation | Completed | No outcome recorded |
| Phase 1 | NCT04265456 | Jan → Jun 2020 | — | Nevakar, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT05370716 | Nov 2019 → Apr 2020 | — | CrystalGenomics, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT03191136 | May → Jun 2017 | neuropathy, painful | Yuhan Corporation | Completed | No outcome recorded |
| Phase 1 | NCT03618589 | Nov 2016 → Dec 2019 | neuropathy, painful | Seoul National University Hospital | Unknown | No outcome recorded |
| Phase 1 | NCT02783183 | Jun → Aug 2016 | neuropathy, painful | Yuhan Corporation | Completed | No outcome recorded |
| Phase 1 | NCT02725112 | Feb → May 2016 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 1 | NCT02783638 | Jan → Apr 2016 | neuropathy, painful | Yuhan Corporation | Completed | No outcome recorded |
| Phase 1 | NCT02349607 | Jan → Mar 2015 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT02327000 | Oct 2014 | — | GL Pharm Tech Corporation | Completed | No outcome recorded |
| Phase 1 | NCT01638273 | Feb → Jul 2014 | — | GL Pharm Tech Corporation | Completed | No outcome recorded |
| Phase 1 | NCT02037165 | Jan → Apr 2014 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02326987 | Oct → Nov 2013 | — | GL Pharm Tech Corporation | Completed | No outcome recorded |
| Phase 1 | NCT01808300 | Feb → Jul 2013 | — | Unimed Pharmaceuticals | Completed | No outcome recorded |
| Phase 1 | NCT02103686 | Nov → Dec 2012 | — | IlDong Pharmaceutical Co Ltd | Completed | No outcome recorded |
| Phase 1 | NCT01443169 | Mar → Apr 2012 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01420913 | Aug 2011 | — | Yuhan Corporation | Completed | No outcome recorded |
| Phase 1 | NCT01342198 | Jun → Jul 2011 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01321671 | Apr → Jun 2011 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01270815 | Mar → Apr 2011 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01257529 | Mar → Apr 2011 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01291524 | Feb → May 2011 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01257516 | Feb → Mar 2011 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01220219 | Nov 2010 → Jan 2011 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01202422 | Oct → Nov 2010 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01202435 | Oct → Nov 2010 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01080612 | Apr → Jun 2010 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01009541 | Nov → Dec 2009 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00760474 | Jan 2009 → Mar 2011 | fibromyalgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 1/24 trials | ||||||
| Phase 1/2 | NCT05442931 | May → Oct 2022 | — | Minia University | Unknown | No outcome recorded |
| Phase 1/2 | NCT02482818 | Sep 2015 → Dec 2021 | — | Ottawa Hospital Research Institute | Unknown | No outcome recorded |
| Phase 1/2 | NCT01333956 | May 2011 → Mar 2013 | — | Hospital for Special Surgery, New York | Completed | No outcome recorded |
| Phase 1/2 | NCT00437281 | Apr 2007 → Nov 2012 | focal epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 240 trials | ||||||
| Phase 2 | NCT07275762 | Feb → Jul 2026 overdue | postherpetic neuralgia | Neurodawn Pharmaceutical Co., Ltd. | Recruiting | No outcome recorded |
| Phase 2 | NCT06614322 | Jan 2026 → Jun 2028 expected | chemotherapy-induced neuropathy, diabetic polyneuropathy, neuropathy, painful | University of Rochester | Recruiting | No outcome recorded |
| Phase 2 | NCT06150898 | May 2025 → Apr 2027 expected | estrogen-receptor positive breast cancer | Jules Bordet Institute | Recruiting | No outcome recorded |
| Phase 2 | NCT06490484 | Apr → Jul 2024 | diabetic polyneuropathy | Haisco Pharmaceutical Group Co., Ltd. | Unknown | No outcome recorded |
| Phase 2 | NCT05995535 | Jan 2024 → Aug 2026 overdue | substance withdrawal syndrome | University of Pennsylvania | Recruiting | No outcome recorded |
| Phase 2 | NCT05967052 | Oct 2023 → Sep 2025 | long COVID-19, myalgic encephalomeyelitis/chronic fatigue syndrome | National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland | Terminated | No outcome recorded |
| Phase 2 | NCT04173390 | Mar → Dec 2021 | — | InCor Heart Institute | Unknown | No outcome recorded |
| Phase 2 | NCT04322305 | Jan 2021 → Jun 2025 | alcohol dependence | New York State Psychiatric Institute | Suspended | No outcome recorded |
| Phase 2 | NCT04218240 | Dec 2020 → Aug 2023 | substance withdrawal syndrome | University of Pennsylvania | Completed | No outcome recorded |
| Phase 2 | NCT04221165 | Aug 2020 → Sep 2023 | head and neck cancer, mucositis | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Completed | No outcome recorded |
| Phase 2 | NCT04495283 | Jul → Nov 2020 | — | Nevakar, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT05083793 | Apr 2020 → Jan 2022 | — | Assiut University | Unknown | No outcome recorded |
| Phase 2 | NCT04181346 | Sep 2019 → Feb 2020 | — | Faculdade de Medicina do ABC | Unknown | No outcome recorded |
| Phase 2 | NCT03652818 | Jun → Sep 2018 | dental pulp disorder | Nevakar, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT03256253 | Feb 2018 → May 2019 | alcohol-related disorders | New York State Psychiatric Institute | Completed | No outcome recorded |
| Phase 2 | NCT03669081 | Sep 2016 → Sep 2018 | neuropathy, painful | University of Utah | Completed | No outcome recorded |
| Phase 2 | NCT03407430 | Jan 2016 → Jun 2017 | breast cancer, lymphoma | UNC Lineberger Comprehensive Cancer Center | Terminated | No outcome recorded |
| Phase 2 | NCT02607254 | Sep 2015 → Jul 2018 | idiopathic small fibers neuropathy | Johns Hopkins University | Completed | No outcome recorded |
| Phase 2 | NCT02924675 | Jun 2015 → Dec 2018 | ear infection | University Hospital, Lille | Terminated | No outcome recorded |
| Phase 2 | NCT02372578 | May 2015 → May 2016 | diabetic polyneuropathy | Astellas Pharma Global Development, Inc. | Terminated | No outcome recorded |
| Phase 2 | NCT02215252 | Nov 2014 → Jul 2015 | diabetic polyneuropathy | Pfizer | Completed | No outcome recorded |
| Phase 2 | NCT03049605 | Jan 2014 → Jan 2015 | diabetes mellitus | Imam Abdulrahman Bin Faisal University | Completed | No outcome recorded |
| Phase 2 | NCT01821430 | Mar 2013 → Feb 2016 | chronic pain syndrome | Georgetown University | Terminated | No outcome recorded |
| Phase 2 | NCT01904097 | Mar 2013 → Jul 2014 | fibromyalgia | Hospital de Clinicas de Porto Alegre | Unknown | No outcome recorded |
| Phase 2 | NCT01637077 | Jan 2012 → Nov 2013 | peripheral neuropathy | Academic and Community Cancer Research United | Completed | No outcome recorded |
| Phase 2 | NCT01314222 | Mar 2011 → Mar 2012 | diabetic polyneuropathy | Bristol-Myers Squibb | Completed | No outcome recorded |
| Phase 2 | NCT00929344 | Jul 2009 → Oct 2014 | alcohol dependence | The Scripps Research Institute | Completed | No outcome recorded |
| Phase 2 | NCT00837941 | Apr → Aug 2009 | diabetic polyneuropathy | Merck Sharp & Dohme LLC | Withdrawn | No outcome recorded |
| Phase 2 | NCT00853229 | Feb 2009 → Apr 2013 | vulvitis, vulvodynia | The Cleveland Clinic | Terminated | No outcome recorded |
| Phase 2 | NCT00599638 | Apr → Dec 2008 | postherpetic neuralgia | Pfizer | Completed | No outcome recorded |
| Phase 2 | NCT00676403 | Apr 2008 → Jan 2009 | restless legs syndrome | Viatris Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00643760 | Mar 2008 → Feb 2009 | diabetic polyneuropathy | XenoPort, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00637975 | Sep 2007 → Dec 2010 | cancer | Associazione Progetto Oncologia UMAN.A | Completed | No outcome recorded |
| Phase 2 | NCT00334685 | Aug 2006 → Oct 2007 | — | Pfizer | Terminated | No outcome recorded |
| Phase 2 | NCT00352651 | Jun → Dec 2006 | herpes zoster, postherpetic neuralgia | University of California, San Francisco | Terminated | No outcome recorded |
| Phase 2 | NCT00558753 | Apr 2006 → Jun 2010 | complex regional pain syndrome | Rush University Medical Center | Completed | No outcome recorded |
| Phase 2 | NCT00245609 | Jan → Oct 2006 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00746681 | Dec 2005 → Nov 2006 | overactive bladder | Pfizer | Completed | No outcome recorded |
| Phase 2 | NCT00141414 | Nov 1997 → Oct 2005 | epilepsy | Pfizer | Completed | No outcome recorded |
| Phase 2 | NCT01675986 | ? → Nov 2014 | anxiety | Poitiers University Hospital | Completed | No outcome recorded |
| Phase 2/311 trials | ||||||
| Phase 2/3 | NCT06117917 | Nov 2023 → May 2024 | chronic pain syndrome | Beijing Tiantan Hospital | Unknown | No outcome recorded |
| Phase 2/3 | NCT05509946 | Oct 2022 → Apr 2023 | — | Indonesia University | Unknown | No outcome recorded |
| Phase 2/3 | NCT05160493 | Dec 2021 → Dec 2023 | chronic pain syndrome | Beijing Tiantan Hospital | Completed | No outcome recorded |
| Phase 2/3 | NCT05096468 | Dec 2021 → Jun 2022 | spinal cord neoplasm | Beijing Tiantan Hospital | Completed | No outcome recorded |
| Phase 2/3 | NCT04122196 | Jun 2020 → Jul 2023 | substance dependence, urolithiasis | University of Missouri-Columbia | Completed | No outcome recorded |
| Phase 2/3 | NCT03232021 | Aug 2017 → Dec 2018 | — | Saint Savvas Anticancer Hospital | Withdrawn | No outcome recorded |
| Phase 2/3 | NCT03229668 | Jul 2017 → Dec 2019 | — | Saint Savvas Anticancer Hospital | Completed | No outcome recorded |
| Phase 2/3 | NCT02701764 | Jul 2016 → Dec 2018 | dry eye syndrome | University of Miami | Completed | No outcome recorded |
| Phase 2/3 | NCT02639533 | Dec 2014 → Jan 2017 | fibromyalgia | Hospital de Clinicas de Porto Alegre | Completed | No outcome recorded |
| Phase 2/3 | NCT01701921 | Jul 2011 → Feb 2016 | — | Larissa University Hospital | Completed | No outcome recorded |
| Phase 2/3 | NCT00370656 | Feb 2007 → May 2009 | diabetes mellitus, peripheral neuropathy | University of Surrey | Completed | No outcome recorded |
| Phase 394 trials | ||||||
| Phase 3 | NCT07712913 | Jun 2026 → Jun 2027 expected | diabetic neuropathy, neuropathy, painful, postherpetic neuralgia | Brainfarma | Recruiting | No outcome recorded |
| Phase 3 | NCT06383702 | May 2024 → Apr 2025 | diabetic polyneuropathy | CSPC Ouyi Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
| Phase 3 | NCT06516094 | Apr 2024 → Jan 2025 | chronic pain syndrome | Laboratorios Silanes S.A. de C.V. | Completed | No outcome recorded |
| Phase 3 | NCT06180707 | Jan → Mar 2024 | dentin sensitivity | Federal University of Pará | Unknown | No outcome recorded |
| Phase 3 | NCT05324059 | Jul 2022 → Apr 2023 | neuropathy, painful | Laboratorios Silanes S.A. de C.V. | Completed | No outcome recorded |
| Phase 3 | NCT04517110 | Apr 2021 → Sep 2022 | substance-related disorder | Hamilton Health Sciences Corporation | Terminated | No outcome recorded |
| Phase 3 | NCT04161027 | Feb 2020 → Apr 2022 | restless legs syndrome | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT03928093 | Aug 2019 → Mar 2023 | epidermolysis bullosa dystrophica, neuropathy, painful | The Hospital for Sick Children | Completed | No outcome recorded |
| Phase 3 | NCT03927781 | Apr → Oct 2019 | nephrolithiasis | University of Missouri-Columbia | Completed | No outcome recorded |
| Phase 3 | NCT03216187 | Jan 2018 → Jun 2024 | — | Benno Rehberg-Klug | Terminated | No outcome recorded |
| Phase 3 | NCT02884908 | Jul 2017 → Jan 2022 | alcohol-related disorders, post-traumatic stress disorder | University of Maryland, Baltimore | Completed | No outcome recorded |
| Phase 3 | NCT02985216 | Feb 2017 → Apr 2018 | neuropathy, painful | Yuhan Corporation | Completed | No outcome recorded |
| Phase 3 | NCT02868814 | May 2016 → May 2019 | fibromyalgia | Jiangsu HengRui Medicine Co., Ltd. | Unknown | No outcome recorded |
| Phase 3 | NCT03221907 | Apr 2016 → Jan 2019 | mononeuropathy | Daewon Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT02868801 | Mar 2015 → Jun 2017 | postherpetic neuralgia | Jiangsu HengRui Medicine Co., Ltd. | Unknown | No outcome recorded |
| Phase 3 | NCT02187471 | Jan 2015 → Jan 2017 | fibromyalgia | Daiichi Sankyo | Completed | No outcome recorded |
| Phase 3 | NCT02374567 | Jan 2015 → Jun 2017 | anxiety disorder, dementia, depressive disorder, schizophrenia +1 | Hannover Medical School | Terminated | No outcome recorded |
| Phase 3 | NCT02240199 | Nov 2014 → Jan 2016 | chronic pain syndrome, myofascial pain syndrome | McMaster University | Completed | No outcome recorded |
| Phase 3 | NCT02072824 | Sep 2014 → Mar 2018 | focal epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01863810 | Aug 2013 → Oct 2014 | diabetic neuropathy | KunWha Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
| Phase 3 | NCT01747915 | Apr 2013 → Feb 2019 | epilepsy with generalized tonic-clonic seizures | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT03031340 | May → Sep 2012 | — | Montefiore Medical Center | Terminated | No outcome recorded |
| Phase 3 | NCT01463306 | Feb 2012 → Aug 2019 | epilepsy with generalized tonic-clonic seizures, focal epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01387607 | Feb 2012 → Oct 2016 | fibromyalgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01455415 | Dec 2011 → Nov 2013 | diabetic polyneuropathy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01432236 | Oct 2011 → Jul 2013 | fibromyalgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01474772 | Oct 2011 → Jul 2013 | diabetic polyneuropathy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01389596 | Sep 2011 → Aug 2016 | focal epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01332149 | Jul 2011 → Apr 2014 | diabetic polyneuropathy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01271933 | Mar 2011 → Jul 2012 | fibromyalgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01270828 | Mar 2011 → Sep 2014 | postherpetic neuralgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01262677 | Feb 2011 → Jul 2012 | focal epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT02927951 | Jan 2011 → Dec 2013 | diabetic polyneuropathy, neuralgia | Eastern Virginia Medical School | Completed | No outcome recorded |
| Phase 3 | NCT01202227 | Sep 2010 → Mar 2012 | neuralgia, spinal cord injury | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01145417 | Jul 2010 → May 2012 | HIV infectious disease, neuropathy, painful | Viatris Inc. | Terminated | No outcome recorded |
| Phase 3 | NCT01061372 | May 2010 → Aug 2011 | restless legs syndrome | Viatris Inc. | Withdrawn | No outcome recorded |
| Phase 3 | NCT01049217 | Apr 2010 → May 2012 | sensory peripheral neuropathy | Viatris Inc. | Terminated | No outcome recorded |
| Phase 3 | NCT01057693 | Mar 2010 → Jan 2012 | diabetic polyneuropathy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01089556 | Mar 2010 → Nov 2011 | diabetic neuropathy | Eli Lilly and Company | Completed | No outcome recorded |
| Phase 3 | NCT00991276 | Dec 2009 → Jun 2011 | restless legs syndrome | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01450345 | Sep 2009 → Dec 2011 | — | University of Malaya | Unknown | No outcome recorded |
| Phase 3 | NCT00830128 | Jul 2009 → Feb 2011 | fibromyalgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00883740 | Jun 2009 → Jun 2010 | fibromyalgia, sleep disorder | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00819988 | May 2009 → Sep 2011 | delirium | Ottawa Hospital Research Institute | Completed | No outcome recorded |
| Phase 3 | NCT00830167 | Mar 2009 → May 2011 | fibromyalgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00806026 | Dec 2008 → May 2011 | restless legs syndrome | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00729690 | Aug 2008 → Jun 2011 | — | Asokumar Buvanendran | Completed | No outcome recorded |
| Phase 3 | NCT00702949 | Jun 2008 → Feb 2010 | breast cancer | Alliance for Clinical Trials in Oncology | Completed | No outcome recorded |
| Phase 3 | NCT00623285 | Apr 2008 → Mar 2011 | — | University of Manitoba | Unknown | No outcome recorded |
| Phase 3 | NCT00596466 | Apr 2008 → Dec 2011 | epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00553280 | Feb 2008 → Jan 2010 | diabetic polyneuropathy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00551135 | Jan 2008 → Jun 2009 | neuropathy, painful | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00553475 | Oct 2007 → Mar 2009 | diabetic neuropathy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00524030 | Sep 2007 → Apr 2011 | focal epilepsy | Viatris Inc. | Terminated | No outcome recorded |
| Phase 3 | NCT00468845 | Jun 2007 → May 2010 | neuropathy, painful | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00448916 | May 2007 → Oct 2013 | epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00447369 | May 2007 → Mar 2008 | migraine disorder | Hospital Militar del General Luis Felipe Brieba Aran | Withdrawn | No outcome recorded |
| Phase 3 | NCT00442546 | May 2007 → Dec 2008 | osteoarthritis | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00372528 | Mar 2007 → Oct 2011 | epilepsy | Viatris Inc. | Terminated | No outcome recorded |
| Phase 3 | NCT00424372 | Jan 2007 → Aug 2008 | postherpetic neuralgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00407745 | Jan 2007 → Feb 2011 | neuralgia, spinal cord injury | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00346034 | Dec 2006 → Feb 2008 | fibromyalgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00413010 | Dec 2006 → Feb 2008 | generalized anxiety disorder | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00394901 | Sep 2006 → Nov 2007 | postherpetic neuralgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00280059 | Aug 2006 → Dec 2009 | focal epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00333866 | Jul 2006 → Nov 2007 | fibromyalgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00264875 | Feb 2006 → Feb 2008 | HIV infectious disease, peripheral neuropathy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00301223 | Feb 2006 → Sep 2007 | neuropathy, painful | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00282997 | Feb → Oct 2006 | fibromyalgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00141219 | Dec 2005 → Dec 2007 | diabetic neuropathy, neuralgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00219544 | Nov 2005 → Feb 2008 | neuropathy, painful | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00230776 | Oct 2005 → Jul 2006 | fibromyalgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00232141 | Oct 2005 → Nov 2007 | HIV infectious disease, peripheral neuropathy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00141258 | Oct 2005 → Aug 2006 | focal epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00159705 | Apr 2005 → Jun 2007 | radiculopathy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00143130 | Apr 2005 → Sep 2007 | epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00151489 | Apr 2005 → Jun 2006 | fibromyalgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00143156 | Mar 2005 → May 2007 | diabetic neuropathy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00151450 | Mar 2005 → Nov 2006 | anxiety | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00151528 | Jan 2005 → Jun 2006 | fibromyalgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00631943 | Nov 2004 → Mar 2005 | neuralgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00645398 | Sep 2004 → Jun 2005 | fibromyalgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00643136 | Nov 2002 → Jun 2004 | focal epilepsy | Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00141375 | Aug 2002 → Jan 2006 | neuropathy, painful | Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00150293 | Mar 2002 → Nov 2005 | focal epilepsy | Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00150436 | Feb 2002 → Jul 2005 | neuralgia | Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00141362 | Oct 2001 → Aug 2005 | — | Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00143143 | Sep 2001 → Feb 2006 | complex partial epilepsy | Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00150449 | Jan 2001 → Mar 2006 | anxiety disorder | Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00150423 | Jan 2001 → Jul 2005 | diabetic polyneuropathy | Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00141336 | Nov 1999 → Jul 2005 | focal epilepsy | Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00141401 | Sep 1999 → Jul 2005 | neuropathy, painful | Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00141245 | Oct 1998 → Nov 2005 | focal epilepsy | Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00141388 | Jul 1998 → Oct 2005 | focal epilepsy | Pfizer | Completed | No outcome recorded |
| Phase 485 trials | ||||||
| Phase 4 | NCT07288528 | Apr 2026 → Apr 2029 expected | hypersensitivity reaction disease | McMaster University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07076069 | Jul 2025 → Jun 2028 expected | rotator cuff syndrome | Montefiore Medical Center | Recruiting | No outcome recorded |
| Phase 4 | NCT06790537 | Apr 2025 → Jun 2026 overdue | — | Post Graduate Institute of Medical Education and Research, Chandigarh | Recruiting | No outcome recorded |
| Phase 4 | NCT06113211 | Oct 2024 → Sep 2026 expected | disease of bone structure, substance-related disorder | Henry Ford Health System | Recruiting | No outcome recorded |
| Phase 4 | NCT06367998 | Sep 2024 → May 2025 overdue | neuropathy, painful, rotator cuff syndrome | The Catholic University of Korea | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06401499 | Jun → Oct 2024 | — | Muhammad Ilyas | Unknown | No outcome recorded |
| Phase 4 | NCT07567924 | Feb 2024 → May 2026 | — | Subas Ali | Completed | No outcome recorded |
| Phase 4 | NCT05804591 | Apr 2023 → Apr 2025 overdue | obesity disorder, substance-related disorder | Medical University of Warsaw | Recruiting | No outcome recorded |
| Phase 4 | NCT05460871 | Feb 2023 → Jan 2024 | osteoarthritis, knee | University of Iowa | Terminated | No outcome recorded |
| Phase 4 | NCT05598905 | Oct 2022 → Jan 2024 | respiratory underresponsiveness to hypoxia and hypercapnia | Leiden University Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT05478382 | Oct 2022 → Dec 2025 | — | Ajou University School of Medicine | Unknown | No outcome recorded |
| Phase 4 | NCT05053126 | Jul 2021 → Apr 2022 | substance abuse | Viatris Specialty LLC | Completed | No outcome recorded |
| Phase 4 | NCT05447364 | Jul 2021 → Sep 2023 | osteoarthritis, knee | Thammasat University | Completed | No outcome recorded |
| Phase 4 | NCT04846673 | May 2021 → Nov 2022 | diabetic polyneuropathy | Yuhan Corporation | Completed | No outcome recorded |
| Phase 4 | NCT04705480 | Apr 2021 → Sep 2024 | — | CAMC Health System | Completed | No outcome recorded |
| Phase 4 | NCT04782310 | Mar → Aug 2021 | — | Cairo University | Unknown | No outcome recorded |
| Phase 4 | NCT04599894 | Nov 2020 → Apr 2021 | neuropathy, painful, osteoarthritis, hip, osteoarthritis, knee | The First Hospital of Jilin University | Completed | No outcome recorded |
| Phase 4 | NCT05624853 | May 2020 → Dec 2022 | neuropathy, painful, type 2 diabetes mellitus | Yuhan Corporation | Completed | No outcome recorded |
| Phase 4 | NCT04246619 | Nov 2019 → Dec 2021 | diabetic polyneuropathy | KRKA | Terminated | No outcome recorded |
| Phase 4 | NCT04495374 | Sep 2019 → Sep 2020 | neuropathy, painful, opioid abuse | Federal University of Alfenas | Terminated | No outcome recorded |
| Phase 4 | NCT04015908 | Aug 2019 → Jan 2023 | substance-related disorder | University of Utah | Completed | No outcome recorded |
| Phase 4 | NCT03714867 | Mar 2019 → Jul 2020 | head and neck cancer, neuropathy, painful | Augusta University | Withdrawn | No outcome recorded |
| Phase 4 | NCT03748290 | Aug 2018 → Nov 2019 | chronic pain syndrome, spinal cord injury | Sheba Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT03584074 | Jul 2018 → May 2019 | lumbar spinal stenosis | Seoul National University Bundang Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT04653792 | Jun 2018 → Apr 2020 | lumbar disk disease, neuropathy, painful | Ziauddin University | Completed | No outcome recorded |
| Phase 4 | NCT03712475 | Jan → Sep 2018 | diabetic polyneuropathy, fibromyalgia, focal epilepsy | Yung Shin Pharm. Ind. Co., Ltd. | Completed | No outcome recorded |
| Phase 4 | NCT03456947 | Jan → Jun 2017 | — | Shanghai Zhongshan Hospital | Completed | No outcome recorded |
| Phase 4 | NCT03241875 | Dec 2016 → Aug 2017 | gallbladder disorder, neuropathy, painful | Faculty of Medicine, Sousse | Completed | No outcome recorded |
| Phase 4 | NCT02747940 | Dec 2015 → Dec 2019 | fibromyalgia, migraine disorder | Taipei Veterans General Hospital, Taiwan | Completed | No outcome recorded |
| Phase 4 | NCT02260388 | Oct 2014 → Sep 2017 | idiopathic progressive polyneuropathy | University of Kansas Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT01852318 | Apr 2014 → May 2015 | — | National Taiwan University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT03017430 | Jan 2014 → Dec 2019 | substance withdrawal syndrome | St. Petersburg Bekhterev Research Psychoneurological Institute | Completed | No outcome recorded |
| Phase 4 | NCT01838044 | Oct 2013 → May 2015 | neuropathy, painful | Viatris Inc. | Terminated | No outcome recorded |
| Phase 4 | NCT01591980 | Aug 2013 → Aug 2014 | chronic pain syndrome, headache disorder | Unity Health Toronto | Withdrawn | No outcome recorded |
| Phase 4 | NCT01801189 | Feb 2013 → Dec 2015 | — | Legacy Health System | Completed | No outcome recorded |
| Phase 4 | NCT02205879 | Jan 2013 → Dec 2019 | alcohol dependence | St. Petersburg Bekhterev Research Psychoneurological Institute | Completed | No outcome recorded |
| Phase 4 | NCT01770964 | Dec 2012 → Jul 2013 | diabetes mellitus, diabetic polyneuropathy | Analgesic Solutions | Unknown | No outcome recorded |
| Phase 4 | NCT01727791 | Dec 2012 → Aug 2013 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT02180880 | Nov 2012 → Aug 2014 | neuralgia, spinal cord injury | Ju Seok Ryu | Completed | No outcome recorded |
| Phase 4 | NCT01603394 | Oct 2012 → Jun 2013 | postherpetic neuralgia | Pfizer | Terminated | No outcome recorded |
| Phase 4 | NCT01768988 | Aug 2012 → Dec 2017 | malignant pancreatic neoplasm | Parc de Salut Mar | Terminated | No outcome recorded |
| Phase 4 | NCT01298466 | Feb 2012 → Feb 2013 | neuralgia | Viatris Inc. | Withdrawn | No outcome recorded |
| Phase 4 | NCT01419405 | Dec 2011 → Mar 2012 | — | Oslo University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01455428 | Dec 2011 → Jan 2014 | postherpetic neuralgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT01397006 | Sep 2011 → Mar 2014 | fibromyalgia | Newton-Wellesley Hospital | Withdrawn | No outcome recorded |
| Phase 4 | NCT01020526 | Sep 2010 → Jun 2015 | fibromyalgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT01020474 | May 2010 → Dec 2014 | fibromyalgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT01158859 | Apr 2010 → Aug 2011 | — | University of Sherbrooke | Completed | No outcome recorded |
| Phase 4 | NCT01128712 | Apr 2010 → Jul 2014 | complex partial epilepsy | Northeast Regional Epilepsy Group | Terminated | No outcome recorded |
| Phase 4 | NCT01073501 | Apr 2010 → Mar 2012 | — | Shaare Zedek Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT01094808 | Mar 2010 → Feb 2011 | — | Mayo Clinic | Completed | No outcome recorded |
| Phase 4 | NCT01059331 | Feb 2010 → Oct 2011 | — | Oslo University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01309074 | Nov 2009 → Dec 2012 | anxiety, epilepsy | Rush University Medical Center | Withdrawn | No outcome recorded |
| Phase 4 | NCT01242332 | Aug 2009 → Oct 2010 | — | Prince of Songkla University | Completed | No outcome recorded |
| Phase 4 | NCT00938548 | Jun → Dec 2009 | neuropathy, painful | Severance Hospital | Completed | No outcome recorded |
| Phase 4 | NCT00624780 | May 2009 → Apr 2012 | generalized anxiety disorder | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00905580 | May → Sep 2009 | neuropathy, painful | Severance Hospital | Completed | No outcome recorded |
| Phase 4 | NCT00994786 | Jan 2009 → Jan 2019 | obsessive-compulsive disorder | McMaster University | Completed | No outcome recorded |
| Phase 4 | NCT00785382 | Jan 2009 → Dec 2011 | — | IWK Health Centre | Completed | No outcome recorded |
| Phase 4 | NCT00781131 | May 2008 → Jul 2010 | — | IWK Health Centre | Completed | No outcome recorded |
| Phase 4 | NCT00663962 | Apr → Nov 2008 | chronic pain syndrome | Queen's University | Completed | No outcome recorded |
| Phase 4 | NCT00791739 | Apr 2008 → Jul 2009 | fibromyalgia | University of Granada | Completed | No outcome recorded |
| Phase 4 | NCT00638443 | Mar 2008 → Mar 2010 | lumbar spinal stenosis | University of Rochester | Completed | No outcome recorded |
| Phase 4 | NCT00631696 | Feb 2008 → Feb 2012 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT01061697 | Jan 2008 → Mar 2010 | radiculopathy, spondylosis, cervical | Singapore General Hospital | Completed | No outcome recorded |
| Phase 4 | NCT00584246 | Nov 2007 → May 2008 | restless legs syndrome | University of South Florida | Withdrawn | No outcome recorded |
| Phase 4 | NCT00855738 | May 2007 → Jun 2009 | focal epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00407797 | Mar 2007 → Aug 2009 | focal epilepsy | Viatris Inc. | Terminated | No outcome recorded |
| Phase 4 | NCT00380874 | Jan 2007 → Mar 2008 | chemotherapy-induced neuropathy | Viatris Inc. | Terminated | No outcome recorded |
| Phase 4 | NCT00407511 | Jan 2007 → Jul 2008 | chemotherapy-induced neuropathy, diabetic polyneuropathy, neuropathy, painful, postherpetic neuralgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00381095 | Dec 2006 → Oct 2010 | bone neoplasm, cancer, chronic pain syndrome | Viatris Inc. | Terminated | No outcome recorded |
| Phase 4 | NCT00351611 | Jul 2006 → Feb 2020 | focal epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00310583 | Jul 2006 → Apr 2008 | neuropathy, painful | Professional Associations Clinic Bergmannsheil | Unknown | No outcome recorded |
| Phase 4 | NCT00573261 | Mar 2006 → May 2008 | diabetic polyneuropathy | Duke University | Completed | No outcome recorded |
| Phase 4 | NCT00292188 | Jan 2006 → May 2008 | neuralgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00378547 | Jan 2006 → Dec 2009 | — | Glostrup University Hospital, Copenhagen | Terminated | No outcome recorded |
| Phase 4 | NCT00288639 | Dec 2005 → Dec 2007 | epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00235261 | Oct 2005 → Jun 2007 | — | Glostrup University Hospital, Copenhagen | Completed | No outcome recorded |
| Phase 4 | NCT00209495 | Jun 2005 → Nov 2007 | neuropathy, painful | Glostrup University Hospital, Copenhagen | Completed | No outcome recorded |
| Phase 4 | NCT00159731 | Jan 2005 → May 2006 | diabetic polyneuropathy | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00156078 | Jan 2005 → May 2007 | diabetic polyneuropathy | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00629681 | Nov 2004 → Feb 2006 | peripheral neuropathy | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00141427 | Nov 2004 → May 2006 | epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00159666 | Oct 2004 → Jun 2006 | postherpetic neuralgia | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00159679 | Sep 2004 → Oct 2005 | diabetic neuropathy | Viatris Inc. | Completed | No outcome recorded |
| Phase not applicable35 trials | ||||||
| — | NCT07549490 | Jul 2026 → Dec 2029 expected | — | National Center for Complementary and Integrative Health (NCCIH) | Not yet recruiting | No outcome recorded |
| — | NCT07630753 | May → Dec 2026 expected | intracranial hypertension | Benha University | Active not recruiting | No outcome recorded |
| — | NCT07635394 | Apr 2026 overdue | irritable bowel syndrome | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| — | NCT07683338 | Feb → Apr 2026 | diabetic polyneuropathy | Syeda Khatoon e Jannat Welfare Foundation | Completed | No outcome recorded |
| — | NCT07606638 | Feb → Jul 2026 overdue | oral cavity squamous cell carcinoma | Mayo Hospital Lahore | Enrolling by invitation | No outcome recorded |
| — | NCT07344467 | Jan 2026 → Jun 2027 expected | anxiety | Tanta University | Recruiting | No outcome recorded |
| — | NCT07598474 | Jan → Jul 2026 overdue | osteoarthritis, knee | University of Faisalabad | Recruiting | No outcome recorded |
| — | NCT07389551 | Jul → Dec 2025 | — | Muhammad Aamir Latif | Completed | No outcome recorded |
| — | NCT06420778 | Jul 2024 → Jun 2025 | postherpetic neuralgia | Zhejiang Chinese Medical University | Unknown | No outcome recorded |
| — | NCT06357260 | Apr 2024 → Feb 2025 | trigeminal neuralgia | Postgraduate Institute of Dental Sciences Rohtak | Unknown | No outcome recorded |
| — | NCT06300346 | Mar → Aug 2024 | — | Sohag University | Unknown | No outcome recorded |
| — | NCT05704374 | Nov → Dec 2023 | fibromyalgia | Istanbul Physical Medicine Rehabilitation Training and Research Hospital | Unknown | No outcome recorded |
| — | NCT05795478 | Oct 2023 → Dec 2024 overdue | chronic pain syndrome | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| — | NCT06155916 | Nov 2022 → Dec 2025 overdue | insomnia, neuropathy, painful | Helsinki University Central Hospital | Recruiting | No outcome recorded |
| — | NCT05322681 | May 2022 → May 2023 | osteoarthritis | The Catholic University of Korea | Unknown | No outcome recorded |
| — | NCT05254652 | May 2022 → May 2023 | osteoarthritis | The Catholic University of Korea | Unknown | No outcome recorded |
| — | NCT05248152 | Jan 2022 → Jan 2024 | — | University Medical Centre Ljubljana | Unknown | No outcome recorded |
| — | NCT06066918 | Jul 2021 → Feb 2026 overdue | spinal cord injury | Loewenstein Hospital | Recruiting | No outcome recorded |
| — | NCT04478526 | Apr 2020 → May 2021 | generalized anxiety disorder | Dr. Nazanin Alavi | Completed | No outcome recorded |
| — | NCT03721432 | May → Nov 2018 | benign shuddering attacks | Beni-Suef University | Completed | No outcome recorded |
| — | NCT03211728 | Jul 2017 → Feb 2019 | — | Yonsei University | Completed | No outcome recorded |
| — | NCT03603626 | Sep 2015 → Dec 2017 | chronic purulent otitis media | Dhulikhel Hospital | Withdrawn | No outcome recorded |
| — | NCT02394951 | Apr 2015 → Apr 2018 | peripheral neuropathy | Washington University School of Medicine | Completed | No outcome recorded |
| — | NCT02340455 | Dec 2014 → Nov 2016 | — | Yonsei University | Withdrawn | No outcome recorded |
| — | NCT02277548 | May 2014 → Apr 2018 | head and neck squamous cell carcinoma, oropharynx cancer | Abramson Cancer Center at Penn Medicine | Completed | No outcome recorded |
| — | NCT01612832 | Jun 2012 → Jun 2013 | — | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| — | NCT01528540 | Apr 2012 → Dec 2014 | chronic pancreatitis | Asian Institute of Gastroenterology, India | Completed | No outcome recorded |
| — | NCT01370915 | Sep 2010 → Nov 2011 | anterior deviation infundibular septum | Samsung Medical Center | Unknown | No outcome recorded |
| — | NCT00967135 | Jun 2010 → Apr 2012 | neuropathy, painful | University of Montreal Hospital Centre (CHUM) | Completed | No outcome recorded |
| — | NCT01097577 | Mar → Jun 2010 | — | 59th Medical Wing | Completed | No outcome recorded |
| — | NCT00954187 | Nov 2009 → Sep 2012 | — | Loma Linda University | Terminated | No outcome recorded |
| — | NCT01366196 | Oct 2008 → Feb 2012 | — | Hospital for Special Surgery, New York | Completed | No outcome recorded |
| — | NCT00610155 | Sep 2008 → Jul 2010 | — | Viatris Inc. | Completed | No outcome recorded |
| — | NCT00891397 | Nov 2007 → Jan 2010 | complex regional pain syndrome type 1 | McMaster University | Terminated | No outcome recorded |
| — | NCT00978341 | Feb 2007 → Oct 2008 | spinal cord injury | Viatris Inc. | Terminated | No outcome recorded |
| Phase not stated1 trial | ||||||
| — | NCT03419949 | — | — | Assiut University | Available | No outcome recorded |
Also used as a comparator or background therapy in 227 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 06 trials | ||||||
| Phase 0 | NCT07400471 Comparator | Feb 2026 → Mar 2027 expected | — | Chattogram International Dental College | Recruiting | No outcome recorded |
| Phase 0 | NCT07016451 Background | Apr 2024 → Sep 2025 | radiation cystitis | Ramathibodi Hospital | Completed | No outcome recorded |
| Phase 0 | NCT05829148 Comparator | May 2023 → Nov 2024 | — | Egymedicalpedia | Unknown | No outcome recorded |
| Phase 0 | NCT05150795 Comparator | Jan 2022 → Dec 2026 expected | — | Ain Shams University | Recruiting | No outcome recorded |
| Phase 0 | NCT03473093 Comparator | Mar 2018 → Mar 2019 | — | Assiut University | Unknown | No outcome recorded |
| Phase 0 | NCT00646451 Comparator | Jun 2006 → Dec 2008 | essential tremor | Baylor College of Medicine | Completed | No outcome recorded |
| Phase 115 trials | ||||||
| Phase 1 | NCT07377721 Comparator | Mar → Sep 2026 expected | diabetic polyneuropathy | Shandong Suncadia Medicine Co., Ltd. | Recruiting | No outcome recorded |
| Phase 1 | NCT05181852 Comparator | Jan → May 2022 | — | Initiator Pharma | Unknown | No outcome recorded |
| Phase 1 | NCT04862845 Comparator | Jul 2021 → Dec 2025 | — | Cairo University | Completed | No outcome recorded |
| Phase 1 | NCT05389150 Comparator | Jan → Feb 2019 | — | Laboratorios Silanes S.A. de C.V. | Completed | No outcome recorded |
| Phase 1 | NCT04499209 Comparator | Oct 2017 → Jan 2018 | — | Xgene Pharmaceutical Group | Completed | No outcome recorded |
| Phase 1 | NCT03261427 Comparator | Sep → Oct 2017 | — | Yungjin Pharm. Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT02260947 Comparator | Oct → Dec 2014 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT02238717 Comparator | Sep → Nov 2014 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT02103647 Comparator | May → Jun 2013 | — | IlDong Pharmaceutical Co Ltd | Completed | No outcome recorded |
| Phase 1 | NCT01719705 Comparator | Nov 2012 → May 2015 | — | Mansoura University | Completed | No outcome recorded |
| Phase 1 | NCT01635751 Comparator | Oct → Nov 2012 | — | GL Pharm Tech Corporation | Completed | No outcome recorded |
| Phase 1 | NCT00654940 Comparator | May 2008 → Feb 2009 | neurological pain disorder | Viatris Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00570310 Comparator | Dec 2007 → Sep 2008 | diabetic neuropathy, neuropathy, small fiber, postherpetic neuralgia | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 1 | NCT00601458 Comparator | Jul 2007 → Jan 2008 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 1 | NCT01122004 Comparator | — | refractive error | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT04622202 Comparator | Nov 2020 → Feb 2021 | anxiety | Zagazig University | Unknown | No outcome recorded |
| Phase 1/2 | NCT05547659 Comparator | Jan 2019 → Apr 2020 | — | October 6 University | Completed | No outcome recorded |
| Phase 231 trials | ||||||
| Phase 2 | NCT06766916 Comparator | May 2025 → Nov 2026 expected | neuropathy, painful | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Recruiting | No outcome recorded |
| Phase 2 | NCT06619860 Comparator | Oct 2024 → Mar 2027 expected | diabetic neuropathy | Vertex Pharmaceuticals Incorporated | Recruiting | No outcome recorded |
| Phase 2 | NCT06221241 Comparator | Mar 2024 → Mar 2025 | diabetic polyneuropathy | Jemincare | Unknown | No outcome recorded |
| Phase 2 | NCT05763550 Comparator | Feb → Jun 2023 | neuralgia | Haisco Pharmaceutical Group Co., Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT05660538 Comparator | Dec 2022 → Oct 2023 | diabetic polyneuropathy | Vertex Pharmaceuticals Incorporated | Completed | No outcome recorded |
| Phase 2 | NCT04660773 Comparator | Aug 2021 → Mar 2022 | — | Alexandria University | Unknown | No outcome recorded |
| Phase 2 | NCT04641273 Comparator | Jan → Sep 2021 | diabetic polyneuropathy | Bayer | Terminated | No outcome recorded |
| Phase 2 | NCT04727502 Comparator | Dec 2020 → Mar 2021 | — | National Cancer Institute, Egypt | Unknown | No outcome recorded |
| Phase 2 | NCT03735368 Comparator | Dec 2018 → Oct 2019 | — | Abd-Elazeem Abd-Elhameed Elbakry | Completed | No outcome recorded |
| Phase 2 | NCT02673866 Comparator | Feb 2016 → Jan 2017 | diabetes mellitus, neuropathy, painful | Daiichi Sankyo | Withdrawn | No outcome recorded |
| Phase 2 | NCT03523832 Comparator | Jul 2015 → Dec 2016 | — | Faculty of Medicine, University of Indonesia | Completed | No outcome recorded |
| Phase 2 | NCT01846182 Comparator | Jun 2015 → Aug 2019 | persian gulf syndrome | VA Office of Research and Development | Terminated | No outcome recorded |
| Phase 2 | NCT02024568 Comparator | Dec 2013 → Mar 2015 | breast cancer | Assaf-Harofeh Medical Center | Unknown | No outcome recorded |
| Phase 2 | NCT01928381 Comparator | Nov 2013 → May 2015 | diabetic neuropathy | AstraZeneca | Completed | No outcome recorded |
| Phase 2 | NCT01939366 Comparator | Sep 2013 → Jan 2015 | chronic pain syndrome, diabetes mellitus, diabetic neuropathy | Tris Pharma, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT01869569 Comparator | Feb 2013 → Oct 2016 | neuropathy, painful | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Completed | No outcome recorded |
| Phase 2 | NCT01688947 Comparator | Sep 2012 → Mar 2014 | postherpetic neuralgia | Purdue Pharma LP | Completed | No outcome recorded |
| Phase 2 | NCT01485094 Comparator | Feb 2012 → Jan 2013 | neuralgia | Grünenthal GmbH | Terminated | No outcome recorded |
| Phase 2 | NCT01504412 Comparator | Jan 2012 → Jun 2013 | diabetic polyneuropathy | Daiichi Sankyo | Completed | No outcome recorded |
| Phase 2 | NCT01571804 Comparator | Dec 2011 → Feb 2012 | — | Mansoura University | Completed | No outcome recorded |
| Phase 2 | NCT01496365 Comparator | Nov 2011 → Sep 2012 | diabetic polyneuropathy | Daiichi Sankyo | Completed | No outcome recorded |
| Phase 2 | NCT01345045 Comparator | Apr → Oct 2011 | diabetic polyneuropathy | AbbVie | Completed | No outcome recorded |
| Phase 2 | NCT01529190 Comparator | Mar → Dec 2011 | — | Federal University of São Paulo | Completed | No outcome recorded |
| Phase 2 | NCT00977197 Comparator | Mar 2010 → Jun 2015 | irritable bowel syndrome | Mayo Clinic | Completed | No outcome recorded |
| Phase 2 | NCT01058642 Comparator | Jan → Dec 2010 | postherpetic neuralgia | Merck & Co., Inc. | Terminated | No outcome recorded |
| Phase 2 | NCT00870454 Comparator | May 2009 → Dec 2010 | diabetic polyneuropathy | SK Life Science, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00838799 Comparator | Feb 2009 → Apr 2010 | diabetic polyneuropathy | Forest Laboratories | Completed | No outcome recorded |
| Phase 2 | NCT00852436 Comparator | Feb 2009 → Oct 2010 | neuropathy, painful | University of Toronto | Terminated | No outcome recorded |
| Phase 2 | NCT00785577 Comparator | Nov 2008 → May 2010 | diabetic neuropathy | Eli Lilly and Company | Completed | No outcome recorded |
| Phase 2 | NCT00696787 Comparator | Jun 2008 → Jan 2009 | fibromyalgia | Wyeth is now a wholly owned subsidiary of Pfizer | Terminated | No outcome recorded |
| Phase 2 | NCT00629889 Comparator | Feb 2008 → May 2012 | central nervous system neoplasm, epilepsy | Dr Andrea Rossetti | Completed | No outcome recorded |
| Phase 2/38 trials | ||||||
| Phase 2/3 | NCT05389813 Comparator | Aug 2021 → Apr 2024 | — | An-Najah National University | Unknown | No outcome recorded |
| Phase 2/3 | NCT04647773 Comparator | Dec 2020 → Nov 2022 | diabetic polyneuropathy | Haisco Pharmaceutical Group Co., Ltd. | Unknown | No outcome recorded |
| Phase 2/3 | NCT04689958 Background | Nov 2020 → Nov 2021 | diabetic polyneuropathy | Duta Wacana Christian University | Unknown | No outcome recorded |
| Phase 2/3 | NCT04689971 Background | Nov 2020 → Nov 2021 | neuropathy, painful | Duta Wacana Christian University | Unknown | No outcome recorded |
| Phase 2/3 | NCT04689984 Background | Nov 2020 → Nov 2021 | diabetic polyneuropathy | Duta Wacana Christian University | Unknown | No outcome recorded |
| Phase 2/3 | NCT04342065 Comparator | Jan 2019 → Jan 2020 | — | South Egypt Cancer Institute | Completed | No outcome recorded |
| Phase 2/3 | NCT01021696 Comparator | Nov 2009 → Jul 2010 | dementia | University of Bergen | Completed | No outcome recorded |
| Phase 2/3 | NCT00755573 Comparator | Oct 2008 → May 2010 | chronic pancreatitis | Aalborg University Hospital | Completed | No outcome recorded |
| Phase 335 trials | ||||||
| Phase 3 | NCT07296770 Background | Oct 2026 → Dec 2027 expected | chronic pain syndrome | University of California, San Francisco | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06715462 Comparator | Apr 2026 → Mar 2028 | diabetic polyneuropathy | Eurofarma Laboratorios S.A. | Withdrawn | No outcome recorded |
| Phase 3 | NCT06628908 Comparator | Oct 2024 → May 2027 expected | diabetic polyneuropathy | Vertex Pharmaceuticals Incorporated | Recruiting | No outcome recorded |
| Phase 3 | NCT06271486 Comparator | Feb → Aug 2024 | headache disorder | Al-Azhar University | Completed | No outcome recorded |
| Phase 3 | NCT04666714 Comparator | May 2023 → Sep 2025 overdue | neuropathy, painful | EMS | Recruiting | No outcome recorded |
| Phase 3 | NCT06025474 Background | Jan → Oct 2023 | burning mouth syndrome | Federico II University | Unknown | No outcome recorded |
| Phase 3 | NCT05539924 Comparator | Sep → Nov 2022 | substance-related disorder | Research Institute of Ophthalmology, Egypt | Unknown | No outcome recorded |
| Phase 3 | NCT03794388 Comparator | Mar 2019 → Nov 2022 | female breast carcinoma | Institut Cancerologie de l'Ouest | Completed | No outcome recorded |
| Phase 3 | NCT03186443 Comparator | Oct 2017 | neuralgia | Second Affiliated Hospital of Guangzhou Medical University | Unknown | No outcome recorded |
| Phase 3 | NCT03302208 Comparator | Jun → Sep 2017 | — | Nesrine El-Refai | Completed | No outcome recorded |
| Phase 3 | NCT02678117 Comparator | Jul 2015 → Dec 2019 | — | National Cancer Institute, Egypt | Completed | No outcome recorded |
| Phase 3 | NCT02311777 Comparator | May 2015 → Sep 2016 | pain agnosia | University of Texas Southwestern Medical Center | Withdrawn | No outcome recorded |
| Phase 3 | NCT02954484 Comparator | Apr 2015 → May 2017 | neuropathy, painful | National University Hospital, Singapore | Completed | No outcome recorded |
| Phase 3 | NCT02187159 Comparator | Nov 2014 → Jul 2016 | fibromyalgia | Daiichi Sankyo | Completed | No outcome recorded |
| Phase 3 | NCT02146430 Comparator | Oct 2014 → Jul 2016 | fibromyalgia | Daiichi Sankyo | Completed | No outcome recorded |
| Phase 3 | NCT01789216 Comparator | Jul 2013 → Dec 2018 | — | Major Extremity Trauma Research Consortium | Completed | No outcome recorded |
| Phase 3 | NCT01701362 Comparator | Oct 2012 → Aug 2015 | neuropathy, painful | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00998816 Comparator | May 2012 → Aug 2014 | chronic pain syndrome | Queen's University | Withdrawn | No outcome recorded |
| Phase 3 | NCT01450163 Comparator | Aug 2011 → Oct 2014 | neuropathy, painful, polyneuropathy | University of Sao Paulo | Completed | No outcome recorded |
| Phase 3 | NCT01271660 Comparator | Jul 2011 → Feb 2018 | cirrhosis of liver | Seoul National University Boramae Hospital | Completed | No outcome recorded |
| Phase 3 | NCT02120703 Comparator | Feb → Oct 2011 | lumbar disk disease | Aga Khan University | Completed | No outcome recorded |
| Phase 3 | NCT00905437 Comparator | Nov 2009 → Jul 2012 | neuropathy, painful | Viatris Inc. | Terminated | No outcome recorded |
| Phase 3 | NCT00879021 Comparator | Sep 2009 → Jun 2012 | spinal cord injury | Nova Scotia Health Authority | Terminated | No outcome recorded |
| Phase 3 | NCT00957177 Comparator | Apr 2009 → Dec 2010 | — | Medical University of Graz | Completed | No outcome recorded |
| Phase 3 | NCT00797797 Background | Nov 2008 → Nov 2009 | fibromyalgia | Forest Laboratories | Completed | No outcome recorded |
| Phase 3 | NCT00740571 Comparator | Sep 2008 → Jun 2010 | cancer, neuralgia | Radboud University Medical Center | Unknown | No outcome recorded |
| Phase 3 | NCT00852683 Comparator | May 2008 → Apr 2013 | female breast carcinoma | Nova Scotia Health Authority | Completed | No outcome recorded |
| Phase 3 | NCT00581685 Comparator | Jan 2008 → Jun 2010 | osteoarthritis | Sunnybrook Health Sciences Centre | Completed | No outcome recorded |
| Phase 3 | NCT00537238 Comparator | Oct 2007 → May 2012 | focal epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00772291 Comparator | May 2007 → Aug 2010 | chronic pain syndrome | Erasmus Medical Center | Completed | No outcome recorded |
| Phase 3 | NCT00414349 Comparator | Dec 2006 → Jan 2008 | neuropathy, painful | Grünenthal GmbH | Completed | No outcome recorded |
| Phase 3 | NCT01391858 Comparator | Dec 2006 → Nov 2012 | — | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
| Phase 3 | NCT00368745 Comparator | Sep 2006 → Aug 2008 | generalized anxiety disorder | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00371033 Comparator | Mar 2006 → Jan 2008 | chronic prostatitis | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Completed | No outcome recorded |
| Phase 3 | NCT00291148 Comparator | Mar 2006 → Jul 2012 | multiple sclerosis, neuropathy, painful | University of Manitoba | Completed | No outcome recorded |
| Phase 462 trials | ||||||
| Phase 4 | NCT07451431 Comparator | Oct 2025 → Mar 2027 expected | diabetic polyneuropathy | Bangladesh Medical University | Recruiting | No outcome recorded |
| Phase 4 | NCT07313111 Background | Jul 2024 → Sep 2025 | diabetic polyneuropathy | Hawler Medical University | Completed | No outcome recorded |
| Phase 4 | NCT06985589 Background | Jan → Aug 2024 | herpes zoster | Second Affiliated Hospital of Xi'an Jiaotong University | Completed | No outcome recorded |
| Phase 4 | NCT07708948 Comparator | Jan 2024 → Oct 2025 | fibromyalgia | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Completed | No outcome recorded |
| Phase 4 | NCT05974501 Background | Sep 2023 → Jan 2024 | osteoarthritis, knee | University of Miami | Completed | No outcome recorded |
| Phase 4 | NCT06187922 Comparator | Sep 2023 → Jun 2025 | — | Bahrain Defence Force Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT05933486 Comparator | Sep → Nov 2023 | fibromyalgia | Quan Jiang | Unknown | No outcome recorded |
| Phase 4 | NCT05640453 Comparator | Dec 2022 → May 2026 overdue | subacute delirium | Tanta University | Recruiting | No outcome recorded |
| Phase 4 | NCT05640479 Comparator | Dec 2022 → Dec 2024 | delirium | Tanta University | Completed | No outcome recorded |
| Phase 4 | NCT05488847 Background | Jun 2022 → Dec 2024 overdue | arthropathy | Henry Ford Health System | Active not recruiting | No outcome recorded |
| Phase 4 | NCT05324761 Comparator | Apr → Jun 2022 | — | Al-Kindy College of Medicine | Completed | No outcome recorded |
| Phase 4 | NCT05221151 Comparator | Jan → May 2022 | anxiety | Menoufia University | Completed | No outcome recorded |
| Phase 4 | NCT05172739 Comparator | Oct 2021 → Nov 2025 overdue | chronic pain syndrome, non-small cell lung carcinoma, substance-related disorder | University of Crete | Recruiting | No outcome recorded |
| Phase 4 | NCT04990804 Background | Aug 2021 → Feb 2022 | spinal cord disorder, substance-related disorder | Vanderbilt University Medical Center | Terminated | No outcome recorded |
| Phase 4 | NCT04766996 Background | May → Dec 2021 | substance-related disorder | Emory University | Terminated | No outcome recorded |
| Phase 4 | NCT05071118 Comparator | Mar → Aug 2021 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 4 | NCT04894864 Comparator | Oct 2020 → Sep 2026 expected | abdominal aortic aneurysm | University of Crete | Recruiting | No outcome recorded |
| Phase 4 | NCT03910088 Comparator | Apr → Jun 2019 | intracranial hypotension | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT04987372 Comparator | Jan 2019 → Dec 2021 | delirium | University Hospital, Ghent | Completed | No outcome recorded |
| Phase 4 | NCT03348735 Comparator | Dec 2018 → Apr 2021 | neuropathy, painful | University Hospital, Antwerp | Terminated | No outcome recorded |
| Phase 4 | NCT03482544 Comparator | Oct 2018 | ischemic disease | Baskent University | Completed | No outcome recorded |
| Phase 4 | NCT03604354 Comparator | Aug 2018 → Mar 2020 | osteoarthritis, knee | All India Institute of Medical Sciences, Bhubaneswar | Completed | No outcome recorded |
| Phase 4 | NCT03809702 Comparator | Jul 2018 → Sep 2019 | herpes zoster | B.P. Koirala Institute of Health Sciences | Completed | No outcome recorded |
| Phase 4 | NCT03060434 Background | Jun 2018 → Dec 2022 overdue | lumbar disk disease, radiculopathy | St Joseph University, Beirut, Lebanon | Active not recruiting | No outcome recorded |
| Phase 4 | NCT03472469 Comparator | Apr 2018 → Jul 2019 | — | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
| Phase 4 | NCT03512574 Comparator | Jan → Mar 2018 | neuropathy, painful | Wonkwang University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT03151213 Comparator | Jan → Jun 2017 | hepatocellular carcinoma | Tanta University | Completed | No outcome recorded |
| Phase 4 | NCT04532684 Comparator | Oct 2016 → Jul 2020 | osteoarthritis, knee | Fatih Sultan Mehmet Training and Research Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02670161 Comparator | May 2016 → Dec 2026 expected | Parkinson disease, brain neoplasm, cognitive impairment with or without cerebellar ataxia, epilepsy +6 | Endeavor Health | Enrolling by invitation | No outcome recorded |
| Phase 4 | NCT03179345 Comparator | Sep → Nov 2015 | — | Depomed | Completed | No outcome recorded |
| Phase 4 | NCT02464813 Comparator | Aug 2015 → Aug 2018 | scoliosis, spondylolisthesis | Turku University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02782169 Comparator | Jun 2015 → Oct 2016 | — | University of Hawaii | Completed | No outcome recorded |
| Phase 4 | NCT02423018 Comparator | Apr 2015 → Mar 2016 | substance-related disorder | Centre for Addiction and Mental Health | Terminated | No outcome recorded |
| Phase 4 | NCT02417935 Comparator | Apr 2015 → May 2017 | diabetic polyneuropathy | Eli Lilly and Company | Completed | No outcome recorded |
| Phase 4 | NCT02285010 Comparator | Nov 2014 → Jan 2016 | — | Mahidol University | Completed | No outcome recorded |
| Phase 4 | NCT02612233 Comparator | Sep 2013 → May 2016 | osteoarthritis, hand | St George's, University of London | Completed | No outcome recorded |
| Phase 4 | NCT01888536 Comparator | Feb → Oct 2013 | spinal stenosis | Yungjin Pharm. Co., Ltd. | Completed | No outcome recorded |
| Phase 4 | NCT01713426 Comparator | Jul 2012 → Sep 2013 | neuropathy, painful, postherpetic neuralgia, traumatic neuropathy | Astellas Pharma Europe Ltd. | Completed | No outcome recorded |
| Phase 4 | NCT01496690 Comparator | Jan 2012 → Dec 2016 | anxiety, schizophrenia | University of Aarhus | Completed | No outcome recorded |
| Phase 4 | NCT01480765 Comparator | Dec 2011 → Mar 2013 | neuropathy, painful | Barts & The London NHS Trust | Completed | No outcome recorded |
| Phase 4 | NCT01479556 Comparator | Dec 2011 → May 2014 | neuropathy, painful, spinal cord injury | Julian Taylor Green | Unknown | No outcome recorded |
| Phase 4 | NCT01555073 Comparator | Oct 2011 → Aug 2013 | leiomyoma | Northwestern University | Terminated | No outcome recorded |
| Phase 4 | NCT01364298 Comparator | Apr 2011 → Jul 2012 | diabetic polyneuropathy | Merck KGaA, Darmstadt, Germany | Completed | No outcome recorded |
| Phase 4 | NCT01331213 Comparator | Apr 2011 → Feb 2013 | irritable bowel syndrome | Mayo Clinic | Completed | No outcome recorded |
| Phase 4 | NCT01352741 Comparator | Mar 2011 → Jan 2012 | neuropathy, painful | Grünenthal GmbH | Completed | No outcome recorded |
| Phase 4 | NCT01226667 Comparator | Jul 2010 → Jul 2012 | fibromyalgia | Osteoporosis Medical Center, Beverly Hills, CA | Completed | No outcome recorded |
| Phase 4 | NCT01116531 Comparator | Apr 2010 → Dec 2012 | diabetic polyneuropathy, postherpetic neuralgia | Turku University Hospital | Withdrawn | No outcome recorded |
| Phase 4 | NCT05432843 Comparator | Mar 2010 → Jan 2023 | — | Universitaire Ziekenhuizen KU Leuven | Unknown | No outcome recorded |
| Phase 4 | NCT01047488 Comparator | Feb 2010 → Mar 2013 | polyneuropathy | Odense University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT00762099 Comparator | May 2009 → Dec 2011 | anxiety | Sunnybrook Health Sciences Centre | Unknown | No outcome recorded |
| Phase 4 | NCT00908375 Comparator | May 2009 → Sep 2012 | intervertebral disk degenerative disorder, radiculopathy, spinal stenosis | Northwestern University | Completed | No outcome recorded |
| Phase 4 | NCT01726205 Comparator | Oct 2008 → May 2012 | — | Attikon Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01344213 Comparator | Jul 2008 → Oct 2009 | — | Chulalongkorn University | Completed | No outcome recorded |
| Phase 4 | NCT00706836 Comparator | Jun → Dec 2008 | anxiety disorder | University of California, San Diego | Completed | No outcome recorded |
| Phase 4 | NCT00537940 Comparator | Feb 2008 → Jul 2013 | complex partial epilepsy | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00584376 Comparator | Dec 2007 → Nov 2010 | essential tremor | University of South Florida | Completed | No outcome recorded |
| Phase 4 | NCT00552526 Comparator | Nov 2007 → Jan 2011 | epilepsy | Oslo University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT00385671 Comparator | Sep 2006 → Aug 2009 | diabetic polyneuropathy | Eli Lilly and Company | Completed | No outcome recorded |
| Phase 4 | NCT00313820 Comparator | Aug 2006 → Sep 2008 | neurological pain disorder | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00403780 Comparator | Jun 2006 → May 2013 | arterial occlusion, limb ischemia | Karolinska Institutet | Terminated | No outcome recorded |
| Phase 4 | NCT00310765 Comparator | Mar 2006 → Aug 2008 | — | Henry Ford Health System | Terminated | No outcome recorded |
| Phase 4 | NCT00353704 Comparator | Nov 2005 → May 2009 | vertebral column disorder | Asker & Baerum Hospital | Completed | No outcome recorded |
| Phase not applicable68 trials | ||||||
| — | NCT07456761 Comparator | Apr → Nov 2026 expected | — | South Egypt Cancer Institute | Not yet recruiting | No outcome recorded |
| — | NCT07421427 Comparator | Feb 2026 → Jan 2027 expected | chronic pain syndrome | Cairo University | Recruiting | No outcome recorded |
| — | NCT07382921 Comparator | Jan → May 2026 overdue | fibromyalgia | Beijing Tiantan Hospital | Not yet recruiting | No outcome recorded |
| — | NCT07208357 Comparator | Oct 2025 → Jun 2027 expected | fibromyalgia | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| — | NCT07230197 Comparator | Sep 2025 → Jun 2027 expected | fibromyalgia | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| — | NCT07196657 Comparator | Sep 2025 → Jun 2027 expected | fibromyalgia | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| — | NCT07186751 Comparator | Sep 2025 → Jun 2027 expected | fibromyalgia | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| — | NCT07171320 Background | Sep 2025 → Jun 2027 expected | fibromyalgia | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| — | NCT07230171 Comparator | Sep 2025 → Jun 2027 expected | fibromyalgia | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| — | NCT07000201 Comparator | Sep → Dec 2025 overdue | anxiety | Cairo University | Not yet recruiting | No outcome recorded |
| — | NCT07157852 Comparator | Sep 2025 → Jun 2027 expected | fibromyalgia | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| — | NCT07515885 Background | Sep 2025 → Dec 2028 expected | herpes zoster | Dexiong Han | Recruiting | No outcome recorded |
| — | NCT07095569 Comparator | Aug 2025 → Aug 2026 overdue | breast cancer | National Cancer Institute, Egypt | Recruiting | No outcome recorded |
| — | NCT06990854 Background | Jul 2025 → Dec 2026 expected | postherpetic neuralgia | Dexiong Han | Not yet recruiting | No outcome recorded |
| — | NCT06344403 Background | Jun 2025 → Oct 2026 expected | herpes zoster | Beijing Tiantan Hospital | Active not recruiting | No outcome recorded |
| — | NCT06969417 Comparator | Apr → Jul 2025 overdue | herpes zoster, postherpetic neuralgia | CMH Kharian Medical College | Recruiting | No outcome recorded |
| — | NCT06914193 Background | Apr 2025 → Jul 2026 overdue | postherpetic neuralgia | Beijing Tiantan Hospital | Not yet recruiting | No outcome recorded |
| — | NCT06914180 Comparator | Apr 2025 → Apr 2026 overdue | postherpetic neuralgia | Beijing Tiantan Hospital | Not yet recruiting | No outcome recorded |
| — | NCT06896994 Background | Apr 2025 → Apr 2026 overdue | postherpetic neuralgia | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| — | NCT07587645 Comparator | Jun → Jul 2024 | — | ISSSTE Hospital Regional "Gral. Ignacio Zaragoza" | Completed | No outcome recorded |
| — | NCT06301061 Comparator | Apr 2024 → Oct 2025 | chronic pain syndrome, neuropathy, painful, radiculopathy | Federico II University | Unknown | No outcome recorded |
| — | NCT06328062 Comparator | Apr 2024 → May 2025 overdue | osteoarthritis | Thammasat University Hospital | Recruiting | No outcome recorded |
| — | NCT07593313 Background | Jan 2024 → Aug 2026 overdue | — | Nanchong Central Hospital | Recruiting | No outcome recorded |
| — | NCT06833203 Comparator | Dec 2023 → May 2025 | — | Cairo University | Completed | No outcome recorded |
| — | NCT05935059 Comparator | Jun 2023 → Mar 2025 | myofascial pain syndrome | National Cancer Institute, Egypt | Completed | No outcome recorded |
| — | NCT05000463 Background | Feb → Aug 2022 | chronic pain syndrome | Assiut University | Unknown | No outcome recorded |
| — | NCT04847245 Comparator | May 2021 → Dec 2022 | chronic pain syndrome, major depressive disorder | Peking University | Unknown | No outcome recorded |
| — | NCT03636958 Background | Feb 2021 → Jul 2025 | epilepsy | Assistance Publique Hopitaux De Marseille | Withdrawn | No outcome recorded |
| — | NCT04662125 Comparator | Dec 2020 → Aug 2023 | — | Zagazig University | Completed | No outcome recorded |
| — | NCT04546334 Background | Sep 2020 → Jun 2021 | postherpetic neuralgia | Tanta University | Completed | No outcome recorded |
| — | NCT04708353 Comparator | Aug 2020 → Oct 2021 | female reproductive system disorder | Zagazig University | Unknown | No outcome recorded |
| — | NCT04316702 Comparator | Mar 2020 → Nov 2023 | fibromyalgia | Assaf-Harofeh Medical Center | Completed | No outcome recorded |
| — | NCT05455944 Comparator | Jan → Dec 2020 | dacryocystitis | Sameh Fathy | Completed | No outcome recorded |
| — | NCT03926000 Comparator | Jun → Nov 2019 | — | Menoufia University | Unknown | No outcome recorded |
| — | NCT03905486 Comparator | Apr → Nov 2019 | fibromyalgia | Yousra Hisham Abdel Fattah | Completed | No outcome recorded |
| — | NCT03890133 Comparator | Apr 2019 → May 2022 | fibromyalgia | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Completed | No outcome recorded |
| — | NCT03797560 Comparator | Mar 2019 → Oct 2021 | fibromyalgia | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Completed | No outcome recorded |
| — | NCT03691038 Comparator | Oct 2018 → Oct 2019 | neuropathy, painful | Kangbuk Samsung Hospital | Terminated | No outcome recorded |
| — | NCT03530280 Comparator | Jun → Oct 2018 | — | Ankara Diskapi Training and Research Hospital | Completed | No outcome recorded |
| — | NCT05558397 Comparator | Apr 2018 → Dec 2022 | — | Federal University of Alfenas | Completed | No outcome recorded |
| — | NCT03494426 Background | Apr 2018 → Jan 2020 | chronic pain syndrome | Assiut University | Completed | No outcome recorded |
| — | NCT04259073 Comparator | Mar → Jun 2018 | — | Hôpital Universitaire Fattouma Bourguiba | Completed | No outcome recorded |
| — | NCT03301025 Comparator | Jan → Mar 2018 | — | Mansoura University | Completed | No outcome recorded |
| — | NCT03942796 Comparator | Jan 2018 → Jun 2019 | — | Mansoura University | Completed | No outcome recorded |
| — | NCT03202459 Comparator | Mar → Sep 2017 | — | Faculdade de Ciências Médicas da Santa Casa de São Paulo | Unknown | No outcome recorded |
| — | NCT03325959 Comparator | Mar 2017 → Jun 2022 | fibromyalgia | Assaf-Harofeh Medical Center | Completed | No outcome recorded |
| — | NCT02690506 Comparator | Feb → May 2016 | — | Kyungpook National University Hospital | Completed | No outcome recorded |
| — | NCT02672202 Comparator | Feb 2016 → May 2017 | chronic pain syndrome | Rambam Health Care Campus | Terminated | No outcome recorded |
| — | NCT02668094 Comparator | Feb → Mar 2016 | — | Kyungpook National University Hospital | Completed | No outcome recorded |
| — | NCT02600247 Background | Nov 2015 → Nov 2016 | osteoarthritis | The Catholic University of Korea | Unknown | No outcome recorded |
| — | NCT02455726 Background | Sep 2015 → Dec 2017 | peripheral arterial disease | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Unknown | No outcome recorded |
| — | NCT03387644 Comparator | Apr 2015 → Nov 2016 | — | Menoufia University | Completed | No outcome recorded |
| — | NCT02170415 Comparator | Jun 2014 → Feb 2017 | neuropathy, painful | Royal Marsden NHS Foundation Trust | Unknown | No outcome recorded |
| — | NCT04600037 Comparator | Apr → Jul 2014 | myofascial pain syndrome | Fatih Sultan Mehmet Training and Research Hospital | Completed | No outcome recorded |
| — | NCT02020122 Comparator | Jan 2014 → Jan 2015 | — | Rambam Health Care Campus | Completed | No outcome recorded |
| — | NCT01940224 Comparator | Jul 2013 → Jan 2018 | — | Larissa University Hospital | Completed | No outcome recorded |
| — | NCT01923948 Comparator | May 2013 → Dec 2014 | hepatocellular carcinoma, neuropathy, painful | Eastern Hepatobiliary Surgery Hospital | Completed | No outcome recorded |
| — | NCT01614236 Comparator | Jul 2012 → Aug 2013 | — | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| — | NCT01359085 Comparator | Jun 2011 → Jun 2012 | pain agnosia | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| — | NCT01359059 Comparator | Jun 2011 → Jun 2013 | — | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| — | NCT01466101 Comparator | Jan 2011 → ? | — | Northwestern University | Withdrawn | No outcome recorded |
| — | NCT01268631 Comparator | Jan 2011 → Jan 2013 | fibromyalgia | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| — | NCT01168531 Comparator | Dec 2009 → Mar 2011 | — | Yonsei University | Completed | No outcome recorded |
| — | NCT01321801 Comparator | Nov 2009 → Oct 2010 | — | Larissa University Hospital | Completed | No outcome recorded |
| — | NCT01359514 Comparator | Apr 2008 → Jan 2014 | — | Rambam Health Care Campus | Completed | No outcome recorded |
| — | NCT00787462 Comparator | Feb 2008 → Feb 2013 | idiopathic small fibers neuropathy | University of Alberta | Terminated | No outcome recorded |
| — | NCT01117766 Comparator | Dec 2006 → Sep 2009 | neuropathy, painful | Pfizer | Completed | No outcome recorded |
| — | NCT00142883 Comparator | Sep 2004 → Sep 2006 | cocaine abuse | Yale University | Terminated | No outcome recorded |
Press releases naming this drug 7 releases
| Date | Issuer | Release |
|---|---|---|
| 2019-05-24 | Pfizer | Pfizer Announces Top-Line Results from Phase 3 Trial of LYRICA® (pregabalin) in Primary Generalized Tonic-Clonic Seizures pfizer.com ↗ |
| 2018-11-27 | Pfizer | Pfizer Receives Six Months Pediatric Exclusivity for LYRICA® (pregabalin) pfizer.com ↗ |
| 2018-05-17 | Pfizer | LYRICA® (pregabalin) Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint pfizer.com ↗ |
| 2017-10-12 | Pfizer | U.S. FDA Approves LYRICA® CR (pregabalin) Extended-Release Tablets CV pfizer.com ↗ |
| 2016-12-01 | Pfizer | LYRICA® (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint pfizer.com ↗ |
| 2015-11-25 | Pfizer | Pfizer Reports Top-Line Results from a Phase 3 Study of LYRICA® (pregabalin) Capsules CV in Adults with Post-Traumatic Peripheral Neuropathic Pain pfizer.com ↗ |
| 2015-03-12 | Pfizer | Pfizer Reports Top-Line Results From A Phase 4 Study Evaluating LYRICA® Capsules CV As A Treatment For Adolescents With Fibromyalgia pfizer.com ↗ |
Evidence & citations 34 cited values
Every value below carries the sentence it was read from. 549 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pregabalin | “Drugs from ACT groups N03A, N05BA, N05CD, H02A or S01EC will be used including prednisolon,levetiracetam, valproate, carbamazepine, oxcarbazepine, topiramate, felbamate,...” NCT00552526 ↗534“PURPOSE: This study compared the efficacy and safety of controlled-release pregabalin (GLA5PR GLARS-NF1 tablets) with those of an immediate-release pregabalin capsule after 12...” PMID 33272643 ↗ Nov 2020 “Antiepileptic drugs allowed are therefore: lamotrigine, levetiracetam, lacosamide, sodium valproate, carbamazepine, oxcarbabazepine, slicarbazepine, pregabalin, gabapentin,...” NCT03636958 ↗ “Pregabalin is an anticonvulsant agent approved by the United States Food and Drug Administration (FDA) for the treatment of neuropathic pain associated with post-herpetic...” NCT01391858 ↗ “The Pregabalin group will receive an oral bolus dose of 300 mg of pregabalin up to two hours prior to the procedure and a 75 mg dose every 12 hours for up to 48 hours following...” NCT01789216 ↗ “If never taken SSRI or SNRI, commence primary medication arm (SSRI: sertraline, escitalopram or Pregabalin/SNRI: duloxetine, venlafaxine) will be described to patient and will...” NCT04478526 ↗ “Patients will receive conservative treatment Acetaminophen (paracetamol) 1000 mg tid and pregabalin (lyrica) 75 mg bid; can be increased to 150 mg bid, oxycodone (oxynorm) 10mg IR PRN.” NCT07095569 ↗ “The basic treatment consisted of penciclovir 0.5g/time per day intravenously, mecobalamin 0.5mg/time three times a day orally and pregabalin 75mg/time twice a day orally for 10 days.” NCT06985589 ↗ “A Open-label, Radomized, Crossover Clinical Trial to Assess the Pharmacokinetics of Pregabalin CR After Multiple Dosing as Compared to Pregabalin IR in Healthy Male Volunteers” NCT02783183 ↗ “The drugs included in the treatment plan are morphine (60 mg/day), pregabalin (150 mg/day) and duloxetine (60 mg/day), available free of charge to the participating patients.” NCT05558397 ↗ “Comparison Between Propofol, Ondansetron and Pregabalin for Control of Emetic Attacks During Caesarean Delivery With Spinal Anesthesia: Randomized Clinical Trial” NCT06300346 ↗ “Participants in the intervention arm of the study (if no contraindications exist) will be administered one pre-procedure dose of 150mg of oral pregabalin.” NCT02170415 ↗ “A new sustained-release (SR) pregabalin formulation (YHD1119) designed for once-daily dosing has recently been developed to improve patient adherence.” PMID 34256964 ↗ Jul 2021 “In the esketamine group, in addition to receiving PRF treatment+pregabalin, patients will also undergo a single intravenous infusion of esketamine.” NCT06914193 ↗ “The medical treatment included optimal glycemic control, vitamin B complex, a lipoic acid, selective serotonin reuptake inhibitors, and pregabalin.” NCT05000463 ↗ “The purpose of this trial to compare the pharmacokinetic characteristics of YNP-1807(Pregabalin 330mg) and Lyrica capsule(Pregabalin 150mg).” NCT03261427 ↗ “pregabalin 150 mg will be given orally, 1 day and 1 hour before surgery (totally two times), patients in Pregabalin Group.” NCT03482544 ↗ “Pregabalin is one of the few agents that have demonstrated effectiveness in the treatment of central NeP in SCI.” NCT00879021 ↗ “Y-4 is a new fixed-dose combination drug product containing two active ingredients of pregabalin and riluzole.” NCT07013773 ↗ “Y-4 is a new fixed-dose combination drug product containing two active ingredients of pregabalin and riluzole.” NCT06935682 ↗ “routine medical treatment of post herpetic neuralgia as controls (Pregabalin, acyclovir, and paracetamol)” NCT04546334 ↗ “Pregabalin is originally used as an antiepileptic drug and identified as treatment for neuropathic pain” NCT04727502 ↗ “Pregabalin and gabapentin are both derived from GABA, but they have no effect on the GABAergic system.” NCT06401499 ↗ “patient will receive for 15 days: Ibuprofen 600 mg bid; pregabalin 75 mg bid; paracetamol 1 g tid” NCT03060434 ↗ “Pregabalin Krka (pregabalin) hard capsules of different strenghts: 25 mg, 75 mg, 150 mg, 300 mg.” NCT04246619 ↗ “A new sustained-release (SR) pregabalin tablet, YHD1119, was formulated for once-daily dosing.” PMID 38197000 ↗ Dec 2023 “Lyrica® (pregabalin 150 mg, hard capsule, given twice daily for a total daily dose of 300 mg)” NCT06715462 ↗ “Regarding pregabalin, the dosage is titrated based on patients'pain intensity and tolerance.” NCT06914180 ↗ “group I patients will receive two capsules of pregabalin (Lyrica) 75 mg (total = 150 mg),” NCT07000201 ↗ “Patients will receive daily 300 mg pregabalin in divided doses (150 mg/12 hours).” NCT06344403 ↗ “standard treatment (pregabalin, gabapentin, or amitriptyline) over eight weeks.” PMID 34984028 ↗ Dec 2021 “One dose of Pregabalin 100mg and Celecoxib 400mg along with interscalene block” NCT07076069 ↗ “1 Tablet contains 300mg of pregabalin. Oral, once a day, for 8 weeks.” NCT01863810 ↗ “PAiN: Pregabalin, Acetaminophen, Naproxen, pantoprazole magnesium” NCT04221165 ↗ “Pregabalin capsules were administered orally, twice daily.” PMID 19301937 ↗ 2009 “another drug called pregabalin in people with fibromyalgia” NCT00797797 ↗ “Lyrica (Pregabalin) 75mg PO 2 hours before the operation” NCT04987372 ↗ “Gabapentin 300mg q8 hours or Pregabalin 75mg twice daily” NCT04990804 ↗ “receiving the combination of pregabalin and duloxetine” NCT06896994 ↗ “Pregabalin 150 mg orally with a small sip of water” NCT04648540 ↗ “neuropathy (duloxetine, pregabalin, amitryptiline)” NCT02670161 ↗ “Lyrica - also known as pregabalin 75mg q12hr” NCT06113211 ↗ “sustained release formulation of pregabalin” NCT02103686 ↗ “one pregabalin capsule (75 mg pregabalin)” NCT07618715 ↗ “Gabapentin, pregabalin, or amitriptyline” NCT04689984 ↗ “Gabapentin, pregabalin, or amitriptyline” NCT04689971 ↗ “Premedication: Pregabalin 50-150mg x2” NCT04894864 ↗ “Premedication: Pregabalin, Midazolam” NCT05172739 ↗ “pregabalin capsules 100mg and 25mg” NCT05995535 ↗ “YHD1119 (Pregabalin 300mg)” NCT02783638 ↗ “* Gabapentin / Pregabalin” NCT07016451 ↗ “pregabalin 150mg” NCT02020122 ↗ “Pregabalin” NCT07296770 ↗ “Pregabalin” NCT03232021 ↗ “Pregabalin” NCT07296770 ↗ |
| Known as | averopreg | “Aim of the work: To compare the efficacy of pregabalin agent (averopreg) alone versus combined pregabalin and serotonin norepinephrine reuptake inhibitor (milnacipran) in the...” NCT03905486 ↗ |
| Known as | Brillior | “1 tab of Pregabalin Brillior 75 mg and 1 tab of Placebo” NCT05447364 ↗ |
| Known as | CI-1008 | “Pregabalin (CI-1008,Lyrica) is a chemical analogue of the mammalian neurotransmitter gamma-aminobutyric acid (GABA),although it does not bind to or activates GABA receptors or...” NCT01128712 ↗4“Randomized, Double-Blind, Multicenter, Placebo-Controlled Study To Evaluate Efficacy And Safety Of Pregabalin (CI-1008) In The Treatment For Pain Associated With Diabetic...” NCT00553475 ↗ “A 13 Week, Double-Blind, Placebo-Controlled Phase 4 Trial of Pregabalin (CI-1008, 600 mg/Day) for Relief of Pain in Subjects With Painful Diabetic Peripheral Neuropathy” NCT00159679 ↗ “Randomized, Double-Blind, Multicenter, Placebo-Controlled Study To Evaluate Efficacy And Safety Of Pregabalin（CI-1008）In The Treatment Of Fibromyalgia” NCT00830167 ↗ “An Open Label Extension Safety Trial of Pregabalin (CI-1008) in Subjects With Diabetic Peripheral Neuropathy” NCT00159731 ↗ |
| Known as | GLA5PR GLARS-NF1 | “PURPOSE: This study compared the efficacy and safety of controlled-release pregabalin (GLA5PR GLARS-NF1 tablets) with those of an immediate-release pregabalin capsule after 12...” PMID 33272643 ↗ Nov 20201“Comparative Pharmacokinetics of a Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and an Immediate-release Pregabalin Capsule in Healthy Male Volunteers.” PMID 30497798 ↗ Nov 2018 |
| Known as | Immediate release capsule(lyrica 150mg * 2/day) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02103647 ↗ |
| Known as | interleukin-6 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00470093 ↗ |
| Known as | Lyrica | “A Phase 4 Randomized Double-Blind Double-Dummy Placebo & Active-Controlled Single-Dose Six-Way Crossover Study Evaluating the Abuse Potential of Lyrica® Taken Orally With...” NCT05053126 ↗62“Pregabalin 25 mg (Lyrica; Pfizer, Germany) or placebo will be administered orally daily at the end of hemodialysis sessions in dialysis patients or every evening in non...” NCT01073501 ↗ “A Randomized, Comparative, Double-Blind, Parallel-Group, Multicenter, Monotherapy, Study Of Pregabalin (Lyrica) And Lamotrigine (Lamictal) In Patients With Newly Diagnosed...” NCT00280059 ↗ “Patients will receive conservative treatment Acetaminophen (paracetamol) 1000 mg tid and pregabalin (lyrica) 75 mg bid; can be increased to 150 mg bid, oxycodone (oxynorm) 10mg IR PRN.” NCT07095569 ↗ “BACKGROUND: Pregabalin (Lyrica(®)) is approved as an immediate-release (IR) formulation for administration twice (BID) or three times (TID) a day depending on indication.” PMID 25078977 ↗ Sep 2014 “Pregabalin (Lyrica) is an anticonvulsant drug with membrane stabilizing and anti-nociceptive effects commonly used for neuropathic pain relief and anxiety disorder.” NCT01359085 ↗ “Pharmacotherapy：① Pregabalin ( Lyrica™ ，Pfizer Inc. America) ② Methylcobalamin ( Mecobalamin tablets， Weicai (China) Pharmaceutical Co., Ltd， China）” NCT06990854 ↗ “Comparatively assess the effectiveness and safety profile of pregabalin (Lyrica) and paroxetine (Paxil) in managing MS-induced neuropathic pain.” NCT00291148 ↗ “Pregabalin is a drug marketed as Lyrica™ in the United States for the treatment of seizures, diabetic neuropathy, and post-herpetic neuralgia.” NCT00352651 ↗ “The purpose of this trial to compare the pharmacokinetic characteristics of YNP-1807(Pregabalin 330mg) and Lyrica capsule(Pregabalin 150mg).” NCT03261427 ↗ “The purpose of this trial to compare the pharmacokinetic characteristics of YHD1119(Pregabalin 300mg) and Lyrica capsule(Pregabalin 150mg).” NCT02783183 ↗ “Drug generic names: celecoxib (celebrex), Pregabalin (Lyrica), acetaminophen/tramadol (ultracet ER), oxycodone (Ircodon)” NCT02600247 ↗ “Fifteen patients with diabetic peripheral neuropathy were treated with antidiabtic drugs and lyrica 150 milligram daily” NCT03049605 ↗ “Pregabalin (PGB) (Lyrica(®) ; Pfizer Inc.) was used as an active control to provide assay sensitivity of the trial.” PMID 23186035 ↗ Nov 2012 “The Effect of Gabapentin (Neurentin) and Pregabalin (Lyrica) in Pain Reduction After Photorefractive Keratectomy” NCT01122004 ↗ “Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures” NCT00524030 ↗ “Naproxen and Pregabalin are commercially available products with trade names of Aleve and Lyrica” NCT04499209 ↗ “Lyrica® (pregabalin 150 mg, hard capsule, given twice daily for a total daily dose of 300 mg)” NCT06715462 ↗ “Interest of Pregabalin (Lyrica) on the Treatment of Reflex Earache in Head and Neck Cancer.” NCT02924675 ↗ “Pregabalin Oral Capsule [Lyrica] 75 mg administered 1 hour prior to the surgical operation” NCT03229668 ↗ “group I patients will receive two capsules of pregabalin (Lyrica) 75 mg (total = 150 mg),” NCT07000201 ↗ “Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia” NCT00883740 ↗ “Lyrica Capsule 150mg/day(Pregabalin 75mg twice a day, after meal) for three days” NCT01638273 ↗ “The initial dose of pregabalin (Lyrica, Pfizer, USA) will be 75mg twice a day.” NCT01116531 ↗ “Can Lyrica (Pregabalin) help prevent severe Dry Eye post LASIK surgery?” NCT02701764 ↗ “Pregabalin is a product marketed by Pfizer under the trade name Lyrica.” PMID 30521533 ↗ Dec 2018 “Lyrica Capsule 150mg/day(Pregabalin 75mg twice a day, fasted)” NCT01635751 ↗ “Pregabalin (Lyrica) for the Treatment of Essential Tremor” NCT00584376 ↗ “one capsule of Pregabalin 75 mg (Lyrica 75 mg, Viatris)” NCT07421427 ↗ “pregabalin (lyrica) 150 mg preoperative 1 hour before” NCT03530280 ↗ “150 mg pregabalin (Lyrica)1 hour prior to surgery” NCT00998816 ↗ “Immediate release capsule(lyrica 150mg * 2/day)” NCT02103647 ↗ “Lyrica - also known as pregabalin 75mg q12hr” NCT06113211 ↗ “Drug: Pregabalin Oral Capsule [Lyrica] 75mg” NCT03232021 ↗ “Groups PREGABALINE : 150 mg de LYRICA®” NCT01675986 ↗ “the other is Pregabalin (Lyrica) 75 mg” NCT06833203 ↗ “Pregabalin, (other name) Lyrica” NCT00879021 ↗ “300 mg/day pregabalin (Lyrica)” NCT01332149 ↗ “pregabalin capsules (Lyrica®)” NCT06935721 ↗ “Drug: pregabalin (Lyrica)” NCT01145417 ↗ “Drug: pregabalin (Lyrica)” NCT01727791 ↗ “Drug: Lyrica (pregabalin)” NCT01455428 ↗ “Lyrica (Pregabalin 150mg)” NCT02783638 ↗ “Drug: pregabalin (Lyrica)” NCT00646451 ↗ “Lyrica® (Pregabalin)” NCT00696787 ↗ “pregabalin (LYRICA)” NCT00372528 ↗ “pregabalin (Lyrica)” NCT01057693 ↗ “Lyrica (pregabalin)” NCT00351611 ↗ “Pregabalin (Lyrica)” NCT00631943 ↗ “pregabalin (Lyrica)” NCT00830128 ↗ “pregabalin (Lyrica)” NCT00468845 ↗ “pregabalin (Lyrica)” NCT00596466 ↗ “Pregabalin (Lyrica)” NCT00584246 ↗ “pregabalin (Lyrica)” NCT01020474 ↗ “Pregabalin (Lyrica)” NCT01370915 ↗ “pregabalin (lyrica)” NCT01391858 ↗ “Pregabalin (Lyrica)” NCT00654940 ↗ “Pregabalin (Lyrica)” NCT00219544 ↗ “Lyrica” NCT04517110 ↗ |
| Known as | LYRICA (pregabalin) | “LYRICA (pregabalin)” NCT01928381 ↗ |
| Known as | Lyrica (Pregabalin) 75mg | “Lyrica (Pregabalin) 75mg” NCT04653792 ↗ |
| Known as | Lyrica 150 milligram | “Lyrica 150 milligram” NCT03049605 ↗ |
| Known as | Lyrica capsule | “Lyrica capsule(Pregabalin 150mg)” NCT01420913 ↗ |
| Known as | PGB | “45 patients will be assigned into each group, by order of their recruitment. Third of the patients in each group will be randomized to Duloxetine (DUL), third to Pregabalin...” NCT02672202 ↗5“The objective of this study was to evaluate the anxiolytic efficacy, and speed of onset of efficacy, of pregabalin (PGB) and venlafaxine-XR (VXR) in patients with generalized...” PMID 21456104 ↗ Mar 2009 “Individuals scheduled for surgery, who are pain free, will be assigned to 3 arms - (1) duloxetine (DUL) (SNRI), (2) pregabalin (PGB) (Ca++ channel ligand) and (3) placebo.” NCT02020122 ↗ “A Multi-site, Double-blind, Randomized, Placebo-controlled, Crossover Study of Pregabalin (Lyrica, PGB) in the Treatment of Essential Tremor” NCT00584376 ↗ “Pregabalin (PGB) is an α2 δ calcium-channel subunit ligand that has previously been shown to reduce chronic pain in multiple conditions.” PMID 26816332 ↗ Jun 2016 “Pregabalin (PGB) (Lyrica(®) ; Pfizer Inc.) was used as an active control to provide assay sensitivity of the trial.” PMID 23186035 ↗ Nov 2012 |
| Known as | PGB-CR | “OBJECTIVES: To assess the efficacy and tolerability of add-on pregabalin controlled-release formulation (PGB-CR) (doses of 165 or 330 mg/day) in patients with partial-onset...” PMID 24962242 ↗ Jun 2014 |
| Known as | PGL | “OBJECTIVE The aim of this study was to assess in-hospital (immediate) postoperative pain scores and analgesic consumption (primary goals) and preoperative anxiety and sleep...” PMID 26871201 ↗ Feb 20162“Pregabalin (PGL) (S+ 3-isobutyl GABA), a structural analog of GABA (Gamma-Aminobutyric Acid) and a derivative of gabapentin in various pain settings, including postoperative pain.” NCT01359059 ↗ “effects of pregabalin (PGL) (S+ 3-isobutyl GABA), a structural analog of GABA and a derivative of gabapentin” NCT01614236 ↗ |
| Known as | Preg (Lyrica) | “Preg (Lyrica®)” NCT05389150 ↗ |
| Known as | Pregabalin Capsules | “In general, for the pregabalin monotherapy group (Pregabalin Capsules, Pfizer, New York, USA), treatment will be initiated at 150 mg/day, administered in two divided doses.” NCT07186751 ↗ |
| Known as | Pregabalin ER | “A: Pregabalin ER tablet formulation, Target release rate, 1 x 330 mg, Oral.” NCT02725112 ↗ |
| Known as | Pregabalin IR | “D: Pregabalin IR capsule formulation, 1 x 300 mg, Oral.” NCT02725112 ↗ |
| Known as | Pregabalin Krka | “Pregabalin Krka (pregabalin) hard capsules of different strenghts: 25 mg, 75 mg, 150 mg, 300 mg.” NCT04246619 ↗ |
| Known as | Pregabalin XR | “Pregabalin XR: extended-release tablet, with an initial dose of 82.5 mg once daily.” NCT07712913 ↗ |
| Known as | Pregabalin: Lyrica | “Pregabalin: Lyrica” NCT01344213 ↗ |
| Known as | S+ 3-isobutyl GABA | “Pregabalin (PGL) (S+ 3-isobutyl GABA), a structural analog of GABA (Gamma-Aminobutyric Acid) and a derivative of gabapentin in various pain settings, including postoperative pain.” NCT01359059 ↗1“effects of pregabalin (PGL) (S+ 3-isobutyl GABA), a structural analog of GABA and a derivative of gabapentin” NCT01614236 ↗ |
| Known as | S-aminomethyl-5-methylhexaninacid | “Pregabalin (S-aminomethyl-5-methylhexaninacid) is a further development of gabapentin.” NCT00353704 ↗ |
| Known as | Y150T | “Eight subjects in Cohort A received a YHD1119 75 mg tablet (Y75T) and a YHD1119 150 mg tablet (Y150T) in each period, and eight subjects in Cohort B received a Y75T.” PMID 38197000 ↗ Dec 2023 |
| Known as | Y75T | “Eight subjects in Cohort A received a YHD1119 75 mg tablet (Y75T) and a YHD1119 150 mg tablet (Y150T) in each period, and eight subjects in Cohort B received a Y75T.” PMID 38197000 ↗ Dec 2023 |
| Known as | YHD1119 | “A new sustained-release (SR) pregabalin formulation (YHD1119) designed for once-daily dosing has recently been developed to improve patient adherence.” PMID 34256964 ↗ Jul 2021 |
| Known as | YHD1119 A | “YHD1119 A(Pregabalin SR 300mg)” NCT01420913 ↗ |
| Known as | YHD1119 B | “YHD1119 B(Pregabalin SR 300mg)” NCT01420913 ↗ |
| Known as | YHD1119 C | “YHD1119 C(Pregabalin SR 300mg)” NCT01420913 ↗ |
| Known as | YNP-1807 | “The purpose of this trial to compare the pharmacokinetic characteristics of YNP-1807(Pregabalin 330mg) and Lyrica capsule(Pregabalin 150mg).” NCT03261427 ↗ |
| Action | Inhibit | “by reducing calcium influx through high-voltage-activated calcium channels containing the alpha2/delta subunit” NCT01359085 ↗ |
| Modality | Protein / enzyme biologic | “recombinant interleukin-6” NCT00470093 ↗ |
| Route | Oral | “75 mg oral pregabalin” PMID 21889410 ↗ Aug 2011 |